| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 5.85e-06 | 18 | 136 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, for other substituted phosphate groups | 1.37e-05 | 22 | 136 | 4 | GO:0016780 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.71e-05 | 28 | 136 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 5.40e-05 | 193 | 136 | 8 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 6.24e-05 | 197 | 136 | 8 | GO:0022834 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 6.30e-05 | 100 | 136 | 6 | GO:0030594 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 7.95e-05 | 151 | 136 | 7 | GO:0008509 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 8.10e-05 | 65 | 136 | 5 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 8.10e-05 | 65 | 136 | 5 | GO:0022824 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRB1 GABRG1 GABRG2 LRRC8C SLC11A2 SLC26A5 ANO1 PKD2L1 GRIK5 GRIN2A NDUFS2 CUL5 KCNH6 PIEZO2 ATP11B SLC4A10 | 1.01e-04 | 793 | 136 | 16 | GO:0015075 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.14e-04 | 37 | 136 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.16e-04 | 70 | 136 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 1.60e-04 | 75 | 136 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.82e-04 | 77 | 136 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 2.16e-04 | 125 | 136 | 6 | GO:0015108 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 2.34e-04 | 18 | 136 | 3 | GO:0022851 | |
| GeneOntologyMolecularFunction | mannose-ethanolamine phosphotransferase activity | 2.74e-04 | 4 | 136 | 2 | GO:0051377 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 2.76e-04 | 19 | 136 | 3 | GO:0004890 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRB1 GABRG1 GABRG2 LRRC8C ANO1 PKD2L1 GRIK5 GRIN2A CUL5 KCNH6 PIEZO2 | 3.11e-04 | 459 | 136 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 3.72e-04 | 50 | 136 | 4 | GO:0099095 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRB1 GABRG1 GABRG2 LRRC8C SLC25A20 SLC11A2 SLC6A17 SLC26A5 ANO1 PKD2L1 GRIK5 GRIN2A NDUFS2 CUL5 KCNH6 SLC44A1 PIEZO2 ATP11B SLC4A10 | 4.10e-04 | 1180 | 136 | 19 | GO:0022857 |
| GeneOntologyMolecularFunction | GABA receptor activity | 4.33e-04 | 22 | 136 | 3 | GO:0016917 | |
| GeneOntologyMolecularFunction | calmodulin-dependent protein phosphatase activity | 4.54e-04 | 5 | 136 | 2 | GO:0033192 | |
| GeneOntologyMolecularFunction | gated channel activity | 4.80e-04 | 334 | 136 | 9 | GO:0022836 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 5.63e-04 | 24 | 136 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 6.15e-04 | 57 | 136 | 4 | GO:1904315 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 6.98e-04 | 103 | 136 | 5 | GO:0005253 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 7.47e-04 | 60 | 136 | 4 | GO:0099529 | |
| GeneOntologyMolecularFunction | mannosyltransferase activity | 8.94e-04 | 28 | 136 | 3 | GO:0000030 | |
| GeneOntologyMolecularFunction | channel activity | GABRB1 GABRG1 GABRG2 LRRC8C ANO1 PKD2L1 GRIK5 GRIN2A CUL5 KCNH6 PIEZO2 | 9.46e-04 | 525 | 136 | 11 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRB1 GABRG1 GABRG2 LRRC8C ANO1 PKD2L1 GRIK5 GRIN2A CUL5 KCNH6 PIEZO2 | 9.61e-04 | 526 | 136 | 11 | GO:0022803 |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.13e-03 | 171 | 136 | 6 | GO:0015103 | |
| GeneOntologyMolecularFunction | transporter activity | GABRB1 GABRG1 GABRG2 LRRC8C SLC25A20 SLC11A2 SLC6A17 SLC26A5 ANO1 PKD2L1 GRIK5 GRIN2A NDUFS2 CUL5 KCNH6 SLC44A1 PIEZO2 ATP11B SLC4A10 | 1.19e-03 | 1289 | 136 | 19 | GO:0005215 |
| GeneOntologyMolecularFunction | calcium-dependent protein serine/threonine phosphatase activity | 1.26e-03 | 8 | 136 | 2 | GO:0004723 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.29e-03 | 118 | 136 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRB1 GABRG1 GABRG2 SLC11A2 SLC26A5 ANO1 PKD2L1 GRIK5 GRIN2A NDUFS2 CUL5 KCNH6 SLC4A10 | 2.04e-03 | 758 | 136 | 13 | GO:0015318 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GABRB1 GABRG1 GABRG2 ITGA11 DRD1 HLA-DQA2 OR13F1 TAAR2 PKD2L1 GPR55 GRIK5 GRIN2A S1PR1 ADRA1D NRXN3 OR52E6 OR52E4 OR52E5 LILRA4 | 2.07e-03 | 1353 | 136 | 19 | GO:0004888 |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 2.43e-03 | 11 | 136 | 2 | GO:0008503 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 2.72e-03 | 140 | 136 | 5 | GO:0099094 | |
| GeneOntologyMolecularFunction | chloride channel activity | 2.84e-03 | 86 | 136 | 4 | GO:0005254 | |
| GeneOntologyMolecularFunction | G-protein alpha-subunit binding | 3.13e-03 | 43 | 136 | 3 | GO:0001965 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 3.42e-03 | 13 | 136 | 2 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 3.42e-03 | 13 | 136 | 2 | GO:0140829 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRB1 GABRG1 GABRG2 LRRC8C DRD1 SLC11A2 SLC6A17 SLC26A5 ANO1 PKD2L1 GRIK5 GRIN2A ACTN2 CEMIP CUL5 KCNH6 PIEZO2 PPP3CA PPP3CC ATP11B SLC4A10 AGRN | 2.94e-06 | 1115 | 134 | 22 | GO:0034220 |
| GeneOntologyBiologicalProcess | regulation of membrane potential | GABRB1 UNC13B GABRG1 GABRG2 DRD1 SLC26A5 ANO1 GRIK5 GRIN2A ACTN2 KCNH6 PIEZO2 PPP3CA CNTNAP2 AGRN | 3.65e-06 | 559 | 134 | 15 | GO:0042391 |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 2.35e-05 | 180 | 134 | 8 | GO:0060078 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 6.44e-05 | 153 | 134 | 7 | GO:0098656 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GABRB1 GABRG1 GABRG2 LRRC8C DRD1 SLC11A2 SLC6A17 SLC26A5 ANO1 PKD2L1 GRIK5 GRIN2A ACTN2 CEMIP CUL5 KCNH6 PIEZO2 PPP3CA PPP3CC ATP11B SLC4A10 AGRN | 7.42e-05 | 1374 | 134 | 22 | GO:0006811 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | GABRB1 GABRG1 GABRG2 DRD1 SLC11A2 SLC6A17 SLC26A5 ANO1 PKD2L1 GRIN2A ACTN2 CEMIP CUL5 KCNH6 PPP3CA PPP3CC SLC4A10 AGRN | 1.05e-04 | 1017 | 134 | 18 | GO:0098660 |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.84e-05 | 25 | 134 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | glutamatergic synapse | UNC13B ROCK2 PRUNE2 GABRG2 DRD1 SLC6A17 ANO1 GRIK5 GRIN2A ACTN2 ERBIN NRXN3 PPP3CA PPP3CC CNTNAP2 AGRN KIF2C | 1.91e-05 | 817 | 134 | 17 | GO:0098978 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GABRB1 GABRG1 GABRG2 LRRC8C ANO1 PKD2L1 GRIK5 GRIN2A KCNH6 CNTNAP2 TMEM262 | 3.30e-05 | 378 | 134 | 11 | GO:0034702 |
| GeneOntologyCellularComponent | outer dynein arm | 5.43e-05 | 12 | 134 | 3 | GO:0036157 | |
| GeneOntologyCellularComponent | transporter complex | GABRB1 GABRG1 GABRG2 LRRC8C ANO1 PKD2L1 GRIK5 GRIN2A NDUFS2 KCNH6 ATP11B CNTNAP2 TMEM262 | 5.45e-05 | 550 | 134 | 13 | GO:1990351 |
| GeneOntologyCellularComponent | transmembrane transporter complex | GABRB1 GABRG1 GABRG2 LRRC8C ANO1 PKD2L1 GRIK5 GRIN2A NDUFS2 KCNH6 CNTNAP2 TMEM262 | 1.41e-04 | 523 | 134 | 12 | GO:1902495 |
| GeneOntologyCellularComponent | presynapse | GABRB1 UNC13B ROCK2 PRUNE2 DRD1 STON1 SLC6A17 ANO1 GRIK5 GRIN2A S1PR1 NRXN3 PPP3CC CNTNAP2 SLC4A10 KIF2C | 1.79e-04 | 886 | 134 | 16 | GO:0098793 |
| GeneOntologyCellularComponent | GABA-A receptor complex | 2.32e-04 | 19 | 134 | 3 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 3.15e-04 | 21 | 134 | 3 | GO:1902710 | |
| GeneOntologyCellularComponent | dynein complex | 3.98e-04 | 54 | 134 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | presynaptic membrane | 4.25e-04 | 277 | 134 | 8 | GO:0042734 | |
| GeneOntologyCellularComponent | chloride channel complex | 4.90e-04 | 57 | 134 | 4 | GO:0034707 | |
| GeneOntologyCellularComponent | nuclear inner membrane | 5.59e-04 | 59 | 134 | 4 | GO:0005637 | |
| GeneOntologyCellularComponent | calcineurin complex | 6.02e-04 | 6 | 134 | 2 | GO:0005955 | |
| GeneOntologyCellularComponent | synaptic membrane | GABRB1 UNC13B GABRG1 GABRG2 DRD1 ANO1 GRIK5 GRIN2A ACTN2 NRXN3 CNTNAP2 | 1.35e-03 | 583 | 134 | 11 | GO:0097060 |
| GeneOntologyCellularComponent | membrane protein complex | GABRB1 GABRG1 GABRG2 LRRC8C TRAV5 ITGA11 DRD1 STON1 HLA-DQA2 ANO1 PKD2L1 GRIK5 GRIN2A NDUFS2 DENND4C KCNH6 RAB5IF CNTNAP2 TMEM262 LILRA4 | 1.38e-03 | 1498 | 134 | 20 | GO:0098796 |
| GeneOntologyCellularComponent | neuron projection membrane | 1.92e-03 | 82 | 134 | 4 | GO:0032589 | |
| GeneOntologyCellularComponent | presynaptic active zone | 2.16e-03 | 141 | 134 | 5 | GO:0048786 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.13e-06 | 14 | 130 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.13e-06 | 14 | 130 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.13e-06 | 14 | 130 | 4 | IPR013602 | |
| Domain | DHC_N2 | 2.13e-06 | 14 | 130 | 4 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 2.13e-06 | 14 | 130 | 4 | IPR011704 | |
| Domain | MT | 2.13e-06 | 14 | 130 | 4 | PF12777 | |
| Domain | AAA_8 | 2.13e-06 | 14 | 130 | 4 | PF12780 | |
| Domain | AAA_5 | 2.13e-06 | 14 | 130 | 4 | PF07728 | |
| Domain | DHC_fam | 2.88e-06 | 15 | 130 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 2.88e-06 | 15 | 130 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.88e-06 | 15 | 130 | 4 | IPR004273 | |
| Domain | DHC_N1 | 1.80e-05 | 8 | 130 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.80e-05 | 8 | 130 | 3 | IPR013594 | |
| Domain | PP2Ac | 8.96e-05 | 13 | 130 | 3 | SM00156 | |
| Domain | Ser/Thr-sp_prot-phosphatase | 8.96e-05 | 13 | 130 | 3 | IPR006186 | |
| Domain | SER_THR_PHOSPHATASE | 8.96e-05 | 13 | 130 | 3 | PS00125 | |
| Domain | GABBAg_rcpt | 1.44e-04 | 3 | 130 | 2 | IPR005437 | |
| Domain | GABAA/Glycine_rcpt | 5.27e-04 | 23 | 130 | 3 | IPR006028 | |
| Domain | Metallophos | 9.50e-04 | 28 | 130 | 3 | PF00149 | |
| Domain | Calcineurin-like_PHP_ApaH | 9.50e-04 | 28 | 130 | 3 | IPR004843 | |
| Domain | Metallo-depent_PP-like | 1.17e-03 | 30 | 130 | 3 | IPR029052 | |
| Domain | - | 1.17e-03 | 30 | 130 | 3 | 3.60.21.10 | |
| Domain | RGS | 1.83e-03 | 35 | 130 | 3 | PF00615 | |
| Domain | RGS | 1.83e-03 | 35 | 130 | 3 | SM00315 | |
| Domain | RGS | 1.99e-03 | 36 | 130 | 3 | PS50132 | |
| Domain | Phosphodiest/P_Trfase | 2.09e-03 | 10 | 130 | 2 | IPR002591 | |
| Domain | Phosphodiest | 2.09e-03 | 10 | 130 | 2 | PF01663 | |
| Domain | LAM_G_DOMAIN | 2.33e-03 | 38 | 130 | 3 | PS50025 | |
| Domain | RGS | 2.51e-03 | 39 | 130 | 3 | IPR016137 | |
| Domain | HlyIII | 2.54e-03 | 11 | 130 | 2 | PF03006 | |
| Domain | AdipoR/HlyIII-related | 2.54e-03 | 11 | 130 | 2 | IPR004254 | |
| Domain | LamG | 3.54e-03 | 44 | 130 | 3 | SM00282 | |
| Domain | Neurotransmitter_ion_chnl_CS | 3.78e-03 | 45 | 130 | 3 | IPR018000 | |
| Domain | Neur_chan_memb | 4.02e-03 | 46 | 130 | 3 | PF02932 | |
| Domain | Neurexin-like | 4.14e-03 | 14 | 130 | 2 | IPR003585 | |
| Domain | 4.1m | 4.14e-03 | 14 | 130 | 2 | SM00294 | |
| Domain | Neurotrans-gated_channel_TM | 4.27e-03 | 47 | 130 | 3 | IPR006029 | |
| Domain | - | 4.27e-03 | 47 | 130 | 3 | 2.70.170.10 | |
| Domain | Neur_chan_LBD | 4.27e-03 | 47 | 130 | 3 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 4.27e-03 | 47 | 130 | 3 | PS00236 | |
| Domain | Neur_channel | 4.27e-03 | 47 | 130 | 3 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 4.27e-03 | 47 | 130 | 3 | IPR006202 | |
| Domain | Gal_mutarotase_SF_dom | 6.11e-03 | 17 | 130 | 2 | IPR011013 | |
| Domain | Lig_chan-Glu_bd | 6.84e-03 | 18 | 130 | 2 | PF10613 | |
| Domain | Glu/Gly-bd | 6.84e-03 | 18 | 130 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 6.84e-03 | 18 | 130 | 2 | SM00918 | |
| Domain | Iontro_rcpt | 6.84e-03 | 18 | 130 | 2 | IPR001320 | |
| Domain | Iono_rcpt_met | 6.84e-03 | 18 | 130 | 2 | IPR001508 | |
| Domain | Lig_chan | 6.84e-03 | 18 | 130 | 2 | PF00060 | |
| Domain | PBPe | 6.84e-03 | 18 | 130 | 2 | SM00079 | |
| Pubmed | theta, a novel gamma-aminobutyric acid type A receptor subunit. | 2.07e-06 | 7 | 137 | 3 | 10449790 | |
| Pubmed | 2.07e-06 | 7 | 137 | 3 | 31178125 | ||
| Pubmed | 3.20e-06 | 300 | 137 | 9 | 19086053 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | SLC6A17 NOB1 PIGG POMT1 RGS12 DENND4C LCLAT1 SLC44A1 ATP11B RAB5IF AGRN PIGO CHST3 | 5.78e-06 | 719 | 137 | 13 | 35337019 |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 24737678 | ||
| Pubmed | GABAA receptor α and γ subunits shape synaptic currents via different mechanisms. | 1.54e-05 | 2 | 137 | 2 | 24425869 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 26845729 | ||
| Pubmed | Genetic variation in the MTHFR gene influences thiopurine methyltransferase activity. | 1.54e-05 | 2 | 137 | 2 | 16306100 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 25354700 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 25354701 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 18987660 | ||
| Pubmed | Molecular signature of MT1-MMP: transactivation of the downstream universal gene network in cancer. | 1.54e-05 | 2 | 137 | 2 | 18519667 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 37831088 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 22764053 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 1321425 | ||
| Pubmed | 1.66e-05 | 13 | 137 | 3 | 35942101 | ||
| Pubmed | 1.78e-05 | 81 | 137 | 5 | 22723691 | ||
| Pubmed | 2.11e-05 | 14 | 137 | 3 | 28826478 | ||
| Pubmed | 2.11e-05 | 14 | 137 | 3 | 22768092 | ||
| Pubmed | 2.11e-05 | 14 | 137 | 3 | 9373155 | ||
| Pubmed | CERS2 BMP2K DZIP1L NOB1 SRCAP ERBIN LCLAT1 SLC44A1 SGMS1 PPP6C TSR1 OTULINL DNA2 AGRN KIF2C | 2.59e-05 | 1084 | 137 | 15 | 11544199 | |
| Pubmed | 3.60e-05 | 47 | 137 | 4 | 8812413 | ||
| Pubmed | 3.90e-05 | 17 | 137 | 3 | 24086760 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 15590926 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 2162844 | ||
| Pubmed | Duplication and relocation of the functional DPY19L2 gene within low copy repeats. | 4.61e-05 | 3 | 137 | 2 | 16526957 | |
| Pubmed | The proline-rich N-terminal sequence of calcineurin Abeta determines substrate binding. | 4.61e-05 | 3 | 137 | 2 | 19154138 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 21254844 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 36974338 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 15973722 | ||
| Pubmed | DNAH6 and Its Interactions with PCD Genes in Heterotaxy and Primary Ciliary Dyskinesia. | 4.61e-05 | 3 | 137 | 2 | 26918822 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 20579975 | ||
| Pubmed | Dopamine and glutamate receptors control social stress-induced striatal ERK1/2 activation. | 4.61e-05 | 3 | 137 | 2 | 33781778 | |
| Pubmed | Direct binding of alpha-actinin enhances TRPP3 channel activity. | 4.61e-05 | 3 | 137 | 2 | 17944866 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 25775128 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 20136833 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 17323057 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 32422433 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 15750039 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 15489953 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 20605790 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 19019179 | ||
| Pubmed | Identification and analysis of axonemal dynein light chain 1 in primary ciliary dyskinesia patients. | 4.61e-05 | 3 | 137 | 2 | 15845866 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 18281286 | ||
| Pubmed | Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology. | 4.61e-05 | 3 | 137 | 2 | 2538761 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 1659808 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 19748501 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 20390408 | ||
| Pubmed | 4.67e-05 | 18 | 137 | 3 | 19078961 | ||
| Pubmed | 4.67e-05 | 18 | 137 | 3 | 18985723 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FAM120B MIS18BP1 U2SURP NOB1 PSMD5 SRCAP PRPF8 ERBIN GTF2H1 PPP6C SMARCA1 AKAP10 MMP14 AGRN CPSF3 KIF2C | 8.94e-05 | 1353 | 137 | 16 | 29467282 |
| Pubmed | Gephyrin plays a key role in BDNF-dependent regulation of amygdala surface GABAARs. | 9.19e-05 | 4 | 137 | 2 | 24096136 | |
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 1318721 | ||
| Pubmed | GPI7 is the second partner of PIG-F and involved in modification of glycosylphosphatidylinositol. | 9.19e-05 | 4 | 137 | 2 | 15632136 | |
| Pubmed | DNAI2 mutations cause primary ciliary dyskinesia with defects in the outer dynein arm. | 9.19e-05 | 4 | 137 | 2 | 18950741 | |
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 11714752 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 11175280 | ||
| Pubmed | LASS2 regulates hepatocyte steatosis by interacting with NDUFS2/OXPHOS related proteins. | 9.19e-05 | 4 | 137 | 2 | 32279995 | |
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 11948245 | ||
| Pubmed | Prostaglandin E2 attenuates preoptic expression of GABAA receptors via EP3 receptors. | 9.19e-05 | 4 | 137 | 2 | 18292084 | |
| Pubmed | 1.14e-04 | 24 | 137 | 3 | 22534482 | ||
| Pubmed | 1.29e-04 | 25 | 137 | 3 | 16006997 | ||
| Pubmed | 1.46e-04 | 67 | 137 | 4 | 20398908 | ||
| Pubmed | Reduced expression of neuropeptide genes in a genome-wide screen of a secretion-deficient mouse. | 1.46e-04 | 67 | 137 | 4 | 16987237 | |
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 11015619 | ||
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 22984995 | ||
| Pubmed | Conditional deletion of pejvakin in adult outer hair cells causes progressive hearing loss in mice. | 1.53e-04 | 5 | 137 | 2 | 28089576 | |
| Pubmed | Are calcineurin genes associated with endurance phenotype traits? | 1.53e-04 | 5 | 137 | 2 | 20107831 | |
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 12574411 | ||
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 24198379 | ||
| Pubmed | FAM209 associates with DPY19L2, and is required for sperm acrosome biogenesis and fertility in mice. | 1.53e-04 | 5 | 137 | 2 | 34471926 | |
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 1321150 | ||
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 15665106 | ||
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 26909801 | ||
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 20593291 | ||
| Pubmed | ARMC4 mutations cause primary ciliary dyskinesia with randomization of left/right body asymmetry. | 1.53e-04 | 5 | 137 | 2 | 23849778 | |
| Pubmed | 1.53e-04 | 5 | 137 | 2 | 23525783 | ||
| Pubmed | 1.58e-04 | 128 | 137 | 5 | 30995482 | ||
| Pubmed | 1.82e-04 | 28 | 137 | 3 | 24448406 | ||
| Pubmed | ROCK2 GABRG1 GABRG2 TCERG1L DZIP1L U2SURP ACTN2 SRCAP PRPF8 ERBIN NRXN3 SACS SMARCA1 DNAH6 DNAH8 ZNF292 | 1.85e-04 | 1442 | 137 | 16 | 35575683 | |
| Pubmed | CERS2 LRRC8C IL32 SLC11A2 MPDU1 PIGG PRPF8 LCLAT1 SLC44A1 ADIPOR1 SGMS1 ATP11B PIGO KIF2C | 2.20e-04 | 1168 | 137 | 14 | 19946888 | |
| Pubmed | 2.29e-04 | 6 | 137 | 2 | 11331379 | ||
| Pubmed | Expression analysis of Lrrk1, Lrrk2 and Lrrk2 splice variants in mice. | 2.29e-04 | 6 | 137 | 2 | 23675505 | |
| Pubmed | Pancreatic expression and mitochondrial localization of the progestin-adipoQ receptor PAQR10. | 2.29e-04 | 6 | 137 | 2 | 18769639 | |
| Pubmed | 2.29e-04 | 6 | 137 | 2 | 10447508 | ||
| Pubmed | 2.29e-04 | 6 | 137 | 2 | 21751815 | ||
| Pubmed | 2.29e-04 | 6 | 137 | 2 | 33347437 | ||
| Pubmed | Mammalian brain phosphoproteins as substrates for calcineurin. | 2.29e-04 | 6 | 137 | 2 | 6330098 | |
| Pubmed | Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. | 2.29e-04 | 6 | 137 | 2 | 10195903 | |
| Pubmed | Gene polymorphisms and osteoporotic fractures: a study in postmenopausal French women. | 2.29e-04 | 6 | 137 | 2 | 19299182 | |
| Pubmed | Matrix metalloproteinase 14 is required for fibrous tissue expansion. | 2.29e-04 | 6 | 137 | 2 | 26390284 | |
| Pubmed | 2.29e-04 | 6 | 137 | 2 | 20848605 | ||
| Pubmed | The cooperative action of CSB, CSA, and UVSSA target TFIIH to DNA damage-stalled RNA polymerase II. | 2.48e-04 | 31 | 137 | 3 | 32355176 | |
| Pubmed | 3.19e-04 | 7 | 137 | 2 | 28126489 | ||
| Pubmed | 3.19e-04 | 7 | 137 | 2 | 7560270 | ||
| Pubmed | 3.19e-04 | 7 | 137 | 2 | 19523047 | ||
| Pubmed | 3.19e-04 | 7 | 137 | 2 | 1315307 | ||
| Pubmed | 3.19e-04 | 7 | 137 | 2 | 17428973 | ||
| Pubmed | 3.19e-04 | 7 | 137 | 2 | 9256245 | ||
| Pubmed | PIEZO2 mediates ultrasonic hearing via cochlear outer hair cells in mice. | 3.19e-04 | 7 | 137 | 2 | 34244441 | |
| GeneFamily | Dyneins, axonemal | 1.83e-06 | 17 | 98 | 4 | 536 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 4.25e-05 | 13 | 98 | 3 | 693 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 1.40e-04 | 19 | 98 | 3 | 563 | |
| GeneFamily | Progestin and adipoQ receptor family | 1.55e-03 | 11 | 98 | 2 | 930 | |
| GeneFamily | Olfactory receptors, family 52 | 2.37e-03 | 49 | 98 | 3 | 165 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-06 | 187 | 137 | 7 | 04dba2ed09ee4180830bdf0191921696697ea234 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-06 | 187 | 137 | 7 | 805dafe22f835ece4dd091d8030d0a63b52a48dd | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.91e-06 | 200 | 137 | 7 | 2f481e2fd248c02a5aa2e0248c16808df142fed2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.91e-06 | 200 | 137 | 7 | bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Mesenchymal|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.91e-06 | 200 | 137 | 7 | e5b7d9622b96bb20c81ac76b4e60e8b44fa9cca1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.91e-06 | 200 | 137 | 7 | dc674124475edf83908b51a4e1454bc2dc4f06fa | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.60e-06 | 148 | 137 | 6 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.28e-06 | 154 | 137 | 6 | ba55a63cfa5e0fb9dfec794f80078a2f0d03d0ad | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-06 | 158 | 137 | 6 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-06 | 158 | 137 | 6 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 9.94e-06 | 159 | 137 | 6 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.15e-05 | 163 | 137 | 6 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 165 | 137 | 6 | dc570154baed59ed109e5369589448e075ba66a9 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-05 | 168 | 137 | 6 | fa7c0303918cea04e3f4c4f3cb079be19004d214 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-05 | 168 | 137 | 6 | 7edcab103c69e928d5c19a0d218ffb3ae32f9e70 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-05 | 171 | 137 | 6 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.55e-05 | 172 | 137 | 6 | bb542f6ca4eb8167129bc84ca1160a54fbb68731 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.55e-05 | 172 | 137 | 6 | aff37b9689b0d30ee7097d997d9588efc475c8fd | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 172 | 137 | 6 | 073a503dc922e3e3ac3528e249b0f8b74402110b | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.83e-05 | 177 | 137 | 6 | d947ba38db1772fc5fdcdc211f7511c4aa699dee | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.83e-05 | 177 | 137 | 6 | d5640f0097878f0dac671e51dc51310278bb2682 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-05 | 179 | 137 | 6 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-05 | 180 | 137 | 6 | b7513b9816a9cb9f3caaddb2a9fed0be1c7f9805 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-05 | 180 | 137 | 6 | f96c5be4705e3d338c0393d2885ac8d5beccd6fd | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.34e-05 | 185 | 137 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.42e-05 | 186 | 137 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 187 | 137 | 6 | 59313a47a6012b2413d7d3673bb05fb7e49fd88f | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 187 | 137 | 6 | 2591fe1552cd10925ad1d8d1f062a057ce6bdad9 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.64e-05 | 189 | 137 | 6 | 160963355256f7c0f2138da80c90de478f5a9fe8 | |
| ToppCell | 18-Airway-Epithelial-Neuroendocrine|Airway / Age, Tissue, Lineage and Cell class | 2.64e-05 | 189 | 137 | 6 | 144beb01b908f2cd0e04513fb84d817e0c3c124e | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.80e-05 | 191 | 137 | 6 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.80e-05 | 191 | 137 | 6 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.80e-05 | 191 | 137 | 6 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.80e-05 | 191 | 137 | 6 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.80e-05 | 191 | 137 | 6 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.89e-05 | 192 | 137 | 6 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.97e-05 | 193 | 137 | 6 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.97e-05 | 193 | 137 | 6 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 3.06e-05 | 194 | 137 | 6 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 3.06e-05 | 194 | 137 | 6 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.06e-05 | 194 | 137 | 6 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 3.06e-05 | 194 | 137 | 6 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.06e-05 | 194 | 137 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.15e-05 | 195 | 137 | 6 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.15e-05 | 195 | 137 | 6 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.24e-05 | 196 | 137 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.24e-05 | 196 | 137 | 6 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.33e-05 | 197 | 137 | 6 | cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.33e-05 | 197 | 137 | 6 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.33e-05 | 197 | 137 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.43e-05 | 198 | 137 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.43e-05 | 198 | 137 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.43e-05 | 198 | 137 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.43e-05 | 198 | 137 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.43e-05 | 198 | 137 | 6 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-CD4+_CTL|Int-URO / Disease, condition lineage and cell class | 3.43e-05 | 198 | 137 | 6 | 717735d755745439f97ba1b71785c73945dfa9c5 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.53e-05 | 199 | 137 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.53e-05 | 199 | 137 | 6 | 6bce8e65859a35cfea1c210f9c9765952d492ed2 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.63e-05 | 200 | 137 | 6 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.63e-05 | 200 | 137 | 6 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.63e-05 | 200 | 137 | 6 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-intermediate_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.63e-05 | 200 | 137 | 6 | d769723f8fcb37d9b86589e0c41c1d7f16393cfe | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.63e-05 | 200 | 137 | 6 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.63e-05 | 200 | 137 | 6 | 94bd00fb6ff0dcb668eb36ec2085f1c3128855b6 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.63e-05 | 200 | 137 | 6 | fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.63e-05 | 200 | 137 | 6 | c6eda342ea0cb37d71d89dbb8d11e819e0745172 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.63e-05 | 200 | 137 | 6 | 177f9ad8dd8635394c575a2b30140184df0bd51e | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.14e-05 | 135 | 137 | 5 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.58e-05 | 137 | 137 | 5 | 9324b55eac55e0cc1e8e450a4b5374d12e9587a3 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Kcnj8_(Mural.Acta2Rgs5.Kcnj8)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.58e-05 | 137 | 137 | 5 | 032f8409d0d179e254c8ff632afbda78852a9889 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Kcnj8_(Mural.Acta2Rgs5.Kcnj8)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.58e-05 | 137 | 137 | 5 | 265a4a50e48b13c8b3b0730f818235f71fbd6baa | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 8.90e-05 | 146 | 137 | 5 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 9.48e-05 | 148 | 137 | 5 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-maDC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-04 | 153 | 137 | 5 | b03375c54aa701817c0fc2c3fef32b870169e697 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-04 | 153 | 137 | 5 | 18bd770a18e642581a6df144d47184c1ac383713 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-04 | 158 | 137 | 5 | 4d997efc36fd8946775fe74dd9ac9ccd5ade64ff | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-2|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 1.37e-04 | 160 | 137 | 5 | d288b0a315f6adc0be4bdc89fa67bf93679a743f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 162 | 137 | 5 | 502ed67f6a572f10ac6e22948a1747d8214eb974 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 162 | 137 | 5 | 82e782096f89cd03d1fdf599ba727d6f23e35e2d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 162 | 137 | 5 | 6bed33b17b59812646dc6a29c1d87413bad86c11 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-04 | 163 | 137 | 5 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-04 | 163 | 137 | 5 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.53e-04 | 164 | 137 | 5 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | mild-Lymphocytic-CD4_T_cells_3|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.62e-04 | 166 | 137 | 5 | f8f8423423d72f0ea0266b59126abb27beb23094 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 1.67e-04 | 167 | 137 | 5 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 168 | 137 | 5 | de1042267407719f19eb3f580a5df0c9cd0e8273 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-04 | 169 | 137 | 5 | 2de213b083f57f47be58427c0ce127fee9f85caa | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.76e-04 | 169 | 137 | 5 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-04 | 169 | 137 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5_RORB_LINC01202|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-04 | 170 | 137 | 5 | 87cac555f16b6c2ef3d1b3a00f992d8bf2237b50 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.86e-04 | 171 | 137 | 5 | 9e00c8191ca9d52151a49baf39f8581cb176fb76 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.86e-04 | 171 | 137 | 5 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.86e-04 | 171 | 137 | 5 | b7cddb8f726a43fb8a37f3e67a3f722e2178fd7a | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.97e-04 | 173 | 137 | 5 | a809be2630d2b91b53b82b5e2bb99e05524597c1 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-04 | 173 | 137 | 5 | 75e26a65071b0d2f30ed0b2aa9859c488f5cf362 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-04 | 173 | 137 | 5 | 26e2e674f5d312fa8f61c11b553dc6101f063b16 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.02e-04 | 174 | 137 | 5 | 0df738309b7b6e77675ea74e7a87e66601b0073d | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.02e-04 | 174 | 137 | 5 | f41d05a3703d7092bd3c4a97c15ae13069aaa4ad | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-04 | 175 | 137 | 5 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.08e-04 | 175 | 137 | 5 | c01a15b2084da4a18f8ff3623f44eb9dfe499f10 | |
| Drug | Tropicamide [1508-75-4]; Down 200; 14uM; MCF7; HT_HG-U133A | PNPLA2 STON1 RGS12 CEMIP ADRA1D HOXD1 MTHFR CNTNAP2 AKAP10 ENPEP SOS2 | 1.98e-08 | 197 | 131 | 11 | 4744_DN |
| Drug | clozapine | GABRB1 GABRG1 GABRG2 SERPINA3 DRD1 GRIK5 GRIN2A ADRA1D PPP3CA PPP3CC MTHFR | 5.56e-07 | 274 | 131 | 11 | CID000002818 |
| Drug | Risperidone [106266-06-2]; Down 200; 9.8uM; HL60; HT_HG-U133A | 1.58e-05 | 192 | 131 | 8 | 2947_DN | |
| Drug | Tolnaftate [2398-96-1]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.83e-05 | 196 | 131 | 8 | 4805_UP | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.97e-05 | 198 | 131 | 8 | 3895_DN | |
| Drug | Dihydroergotoxine mesylate [8067-24-1]; Down 200; 6.4uM; PC3; HT_HG-U133A | 2.04e-05 | 199 | 131 | 8 | 4071_DN | |
| Drug | Tocainide hydrochloride; Up 200; 17.4uM; PC3; HT_HG-U133A | 2.04e-05 | 199 | 131 | 8 | 4256_UP | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.04e-05 | 199 | 131 | 8 | 7226_UP | |
| Drug | gamma-Aminobutyric Acid | 2.91e-05 | 62 | 131 | 5 | ctd:D005680 | |
| Drug | cyclothiazide | 2.93e-05 | 103 | 131 | 6 | CID000002910 | |
| Drug | AC1L1J7N | 3.39e-05 | 64 | 131 | 5 | CID000004902 | |
| Drug | 1-norokadaone | 3.94e-05 | 12 | 131 | 3 | CID003309928 | |
| Drug | enflurane | 4.55e-05 | 68 | 131 | 5 | CID000003226 | |
| Drug | felbamate | 5.24e-05 | 70 | 131 | 5 | CID000003331 | |
| Drug | MK-801 | 5.56e-05 | 296 | 131 | 9 | CID000001207 | |
| Drug | secobarbital | 5.97e-05 | 37 | 131 | 4 | CID000005193 | |
| Drug | Gabrene | 8.15e-05 | 40 | 131 | 4 | CID005361323 | |
| Drug | muscimol | 1.03e-04 | 129 | 131 | 6 | CID000004266 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 1.03e-04 | 186 | 131 | 7 | 5566_UP | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 1.07e-04 | 187 | 131 | 7 | 6995_UP | |
| Drug | Econazole nitrate [24169-02-6]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.10e-04 | 188 | 131 | 7 | 7427_UP | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.14e-04 | 189 | 131 | 7 | 1646_UP | |
| Drug | Gramine [87-52-5]; Up 200; 23uM; HL60; HT_HG-U133A | 1.18e-04 | 190 | 131 | 7 | 2143_UP | |
| Drug | dihydroxyaflavinine | 1.19e-04 | 17 | 131 | 3 | CID000156857 | |
| Drug | AC1L1B1W | 1.25e-04 | 84 | 131 | 5 | CID000001248 | |
| Drug | Propoxycaine hydrochloride [550-83-4]; Down 200; 12uM; PC3; HT_HG-U133A | 1.26e-04 | 192 | 131 | 7 | 7155_DN | |
| Drug | Cefalonium [5575-21-3]; Down 200; 8.8uM; PC3; HT_HG-U133A | 1.30e-04 | 193 | 131 | 7 | 4245_DN | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 1.30e-04 | 193 | 131 | 7 | 3973_DN | |
| Drug | Moxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; PC3; HT_HG-U133A | 1.34e-04 | 194 | 131 | 7 | 1804_DN | |
| Drug | Tadjakonine [11087-94-8]; Up 200; 7.4uM; PC3; HT_HG-U133A | 1.34e-04 | 194 | 131 | 7 | 4599_UP | |
| Drug | Ceforanide [60925-61-3]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.38e-04 | 195 | 131 | 7 | 3309_UP | |
| Drug | Acemetacin [53164-05-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.38e-04 | 195 | 131 | 7 | 5460_DN | |
| Drug | Gentamicine sulfate [1405-41-0]; Up 200; 2.6uM; MCF7; HT_HG-U133A | 1.38e-04 | 195 | 131 | 7 | 7237_UP | |
| Drug | Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.38e-04 | 195 | 131 | 7 | 2702_UP | |
| Drug | Cyclacillin [3485-14-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | 1.38e-04 | 195 | 131 | 7 | 3800_UP | |
| Drug | AG-012559 [369370-06-9]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.43e-04 | 196 | 131 | 7 | 6889_UP | |
| Drug | Trolox [53188-07-1]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.43e-04 | 196 | 131 | 7 | 6007_DN | |
| Drug | Mimosine [500-44-7]; Down 200; 20.2uM; PC3; HT_HG-U133A | 1.43e-04 | 196 | 131 | 7 | 6703_DN | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.43e-04 | 196 | 131 | 7 | 5438_DN | |
| Drug | Sulfadoxine [2447-57-6]; Up 200; 12.8uM; PC3; HT_HG-U133A | 1.43e-04 | 196 | 131 | 7 | 5852_UP | |
| Drug | Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 1.43e-04 | 196 | 131 | 7 | 7200_UP | |
| Drug | Norethynodrel [68-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.43e-04 | 196 | 131 | 7 | 1696_DN | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 1.43e-04 | 196 | 131 | 7 | 6061_UP | |
| Drug | Denatonium benzoate [3734-33-6]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.47e-04 | 197 | 131 | 7 | 5480_UP | |
| Drug | radicicol; Down 200; 0.1uM; SKMEL5; HG-U133A | 1.47e-04 | 197 | 131 | 7 | 493_DN | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.47e-04 | 197 | 131 | 7 | 4764_DN | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 1.47e-04 | 197 | 131 | 7 | 3277_DN | |
| Drug | Pronethalol hydrochloride [51-02-5]; Up 200; 15uM; PC3; HT_HG-U133A | 1.47e-04 | 197 | 131 | 7 | 3984_UP | |
| Drug | Bromopride [4093-35-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.52e-04 | 198 | 131 | 7 | 6037_UP | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Up 200; 9uM; HL60; HT_HG-U133A | 1.52e-04 | 198 | 131 | 7 | 2526_UP | |
| Drug | Methacycline hydrochloride [3963-95-9]; Up 200; 8.4uM; PC3; HT_HG-U133A | 1.52e-04 | 198 | 131 | 7 | 4062_UP | |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.52e-04 | 198 | 131 | 7 | 1070_DN | |
| Drug | Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.52e-04 | 198 | 131 | 7 | 2062_DN | |
| Drug | Flecainide acetate [54143-56-5]; Up 200; 8.4uM; HL60; HT_HG-U133A | 1.52e-04 | 198 | 131 | 7 | 2557_UP | |
| Drug | Gabazine [105538-73-6]; Up 200; 10.8uM; PC3; HT_HG-U133A | 1.52e-04 | 198 | 131 | 7 | 4236_UP | |
| Drug | Quinethazone [73-49-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.52e-04 | 198 | 131 | 7 | 4351_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; HL60; HT_HG-U133A | 1.57e-04 | 199 | 131 | 7 | 6168_DN | |
| Drug | Trolox [53188-07-1]; Up 200; 16uM; MCF7; HT_HG-U133A | 1.57e-04 | 199 | 131 | 7 | 2883_UP | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 1uM; PC3; HT_HG-U133A | 1.57e-04 | 199 | 131 | 7 | 4562_DN | |
| Drug | Sulfanilamide [63-74-1]; Up 200; 23.2uM; MCF7; HT_HG-U133A | 1.57e-04 | 199 | 131 | 7 | 3449_UP | |
| Drug | ikarugamycin; Down 200; 2uM; MCF7; HT_HG-U133A_EA | 1.57e-04 | 199 | 131 | 7 | 918_DN | |
| Drug | Sparteine (-) [90-39-1]; Up 200; 17uM; PC3; HT_HG-U133A | 1.57e-04 | 199 | 131 | 7 | 4568_UP | |
| Drug | Acetohexamide [968-81-0]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.62e-04 | 200 | 131 | 7 | 1829_DN | |
| Drug | Diflorasone Diacetate [33564-31-7]; Down 200; 8uM; PC3; HT_HG-U133A | 1.62e-04 | 200 | 131 | 7 | 4077_DN | |
| Drug | felbamate | 1.67e-04 | 48 | 131 | 4 | ctd:C047360 | |
| Drug | pregnanolone | 1.74e-04 | 90 | 131 | 5 | CID000031402 | |
| Drug | NBQX | 1.74e-04 | 90 | 131 | 5 | CID003272523 | |
| Drug | LX201 | 1.96e-04 | 4 | 131 | 2 | CID006440291 | |
| Drug | suppressor of FK506 1 | 1.96e-04 | 4 | 131 | 2 | CID000419462 | |
| Disease | Alcoholic Intoxication, Chronic | GABRB1 GABRG1 GABRG2 DRD1 GRIN2A TBX19 NRXN3 MTHFR CNTNAP2 ALDH3B2 | 4.09e-07 | 268 | 133 | 10 | C0001973 |
| Disease | Colorectal Carcinoma | UNC13B TCERG1L SLC11A2 GRIN2A GSTM3 POSTN HOXD1 SACS DMKN MTHFR WNT16 DNAH8 PIGO ZNF292 | 3.70e-06 | 702 | 133 | 14 | C0009402 |
| Disease | Bipolar Disorder | GABRB1 GABRG1 DRD1 GRIK5 GRIN2A S1PR1 PPP3CC MTHFR CNTNAP2 AKAP10 DNAH8 | 1.13e-05 | 477 | 133 | 11 | C0005586 |
| Disease | Epilepsy, Rolandic | 6.03e-05 | 3 | 133 | 2 | C0376532 | |
| Disease | Benign Rolandic Epilepsy | 6.03e-05 | 3 | 133 | 2 | C2363129 | |
| Disease | kidney failure (is_implicated_in) | 1.20e-04 | 4 | 133 | 2 | DOID:1074 (is_implicated_in) | |
| Disease | Schizophrenia | GABRB1 GABRG2 DRD1 ACOT6 GRIK5 GRIN2A RGS12 KCNH6 NRXN3 PPP3CC MTHFR RCBTB1 CNTNAP2 | 1.85e-04 | 883 | 133 | 13 | C0036341 |
| Disease | Autistic Disorder | 1.89e-04 | 261 | 133 | 7 | C0004352 | |
| Disease | Colorectal Neoplasms | 2.71e-04 | 277 | 133 | 7 | C0009404 | |
| Disease | serum metabolite measurement | GABRB1 GPD2 TAAR2 PKD2L1 GRIK5 GSTM3 ADRA1D GTF2H1 PPP3CA SULT2A1 ALDH3B2 ARHGAP20 ENPEP | 3.56e-04 | 945 | 133 | 13 | EFO_0005653 |
| Disease | Manic | 4.35e-04 | 78 | 133 | 4 | C0338831 | |
| Disease | schizophrenia (is_implicated_in) | 4.35e-04 | 78 | 133 | 4 | DOID:5419 (is_implicated_in) | |
| Disease | Leukopenia | 5.55e-04 | 8 | 133 | 2 | C0023530 | |
| Disease | abdominal aortic aneurysm (is_marker_for) | 8.86e-04 | 10 | 133 | 2 | DOID:7693 (is_marker_for) | |
| Disease | Methylmalonic acidemia | 8.86e-04 | 10 | 133 | 2 | C0268583 | |
| Disease | Semantic-Pragmatic Disorder | 1.08e-03 | 11 | 133 | 2 | C0454655 | |
| Disease | Methylmalonic aciduria | 1.08e-03 | 11 | 133 | 2 | C1855119 | |
| Disease | Auditory Processing Disorder, Central | 1.08e-03 | 11 | 133 | 2 | C0751257 | |
| Disease | Language Delay | 1.08e-03 | 11 | 133 | 2 | C0023012 | |
| Disease | Language Development Disorders | 1.08e-03 | 11 | 133 | 2 | C0023014 | |
| Disease | Speech Delay | 1.08e-03 | 11 | 133 | 2 | C0241210 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.42e-03 | 49 | 133 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Fulminant Hepatic Failure with Cerebral Edema | 1.52e-03 | 13 | 133 | 2 | C0751197 | |
| Disease | Hepatic Stupor | 1.52e-03 | 13 | 133 | 2 | C0751198 | |
| Disease | Hepatic Encephalopathy | 1.52e-03 | 13 | 133 | 2 | C0019151 | |
| Disease | Hepatic Coma | 1.52e-03 | 13 | 133 | 2 | C0019147 | |
| Disease | Epilepsy | 1.52e-03 | 109 | 133 | 4 | C0014544 | |
| Disease | anemia (is_implicated_in) | 1.77e-03 | 14 | 133 | 2 | DOID:2355 (is_implicated_in) | |
| Disease | Situs ambiguus | 2.04e-03 | 15 | 133 | 2 | C0266642 | |
| Disease | disease free survival, rectum cancer | 2.04e-03 | 15 | 133 | 2 | EFO_0000409, EFO_1000657 | |
| Disease | cleft lip (is_implicated_in) | 2.04e-03 | 15 | 133 | 2 | DOID:9296 (is_implicated_in) | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 2.04e-03 | 15 | 133 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | inherited metabolic disorder (is_implicated_in) | 2.04e-03 | 15 | 133 | 2 | DOID:655 (is_implicated_in) | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 2.04e-03 | 15 | 133 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | blood osmolality measurement | 2.30e-03 | 58 | 133 | 3 | EFO_0007967 | |
| Disease | osteosarcoma (is_implicated_in) | 2.32e-03 | 16 | 133 | 2 | DOID:3347 (is_implicated_in) | |
| Disease | keratoconus | 3.33e-03 | 66 | 133 | 3 | MONDO_0015486 | |
| Disease | X-24309 measurement | 3.63e-03 | 20 | 133 | 2 | EFO_0800872 | |
| Disease | susceptibility to mononucleosis measurement | 3.78e-03 | 69 | 133 | 3 | EFO_0008403 | |
| Disease | hyperglycemia (biomarker_via_orthology) | 4.00e-03 | 21 | 133 | 2 | DOID:4195 (biomarker_via_orthology) | |
| Disease | Neutropenia | 4.00e-03 | 21 | 133 | 2 | C0027947 | |
| Disease | Manic Disorder | 4.09e-03 | 71 | 133 | 3 | C0024713 | |
| Disease | rosacea severity measurement | 4.48e-03 | 147 | 133 | 4 | EFO_0009180 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MKTFAGFSFLFLWLQ | 1 | A0A0B4J249 | |
| EFWMDANRLTFIPGF | 211 | Q96RT1 | |
| AVKQLFPEFEFMWLV | 206 | Q86TW2 | |
| FAKRAAPFNNWMEGA | 521 | P35609 | |
| GSLQFEDKWDFMRPI | 11 | Q93034 | |
| PWFLQKTSFKGRTFM | 81 | Q9UKF6 | |
| IFFKAKWEMPFDPQD | 211 | P01011 | |
| RQAWTTMEKVFLPGF | 481 | O43572 | |
| RFMDFDWFPAFITGA | 1246 | O00468 | |
| KSGFLTFMDTWSNPL | 286 | Q3I5F7 | |
| VPFLFIVGMDDQSWK | 316 | Q3I5F7 | |
| FFQPWLGDTGSDMNK | 76 | Q5JTW2 | |
| PFGSFCNIWVAFDIM | 91 | P21728 | |
| FMKLDSVFIWKEPFG | 11 | P48448 | |
| MSGWNPFGEDNFSKL | 621 | Q9NSY1 | |
| QMAFVGFKGSFRPIW | 1321 | Q8WUJ3 | |
| AFIAGMAVIVDKPWF | 146 | Q96G23 | |
| DAALFWMPNGKTYFF | 416 | P50281 | |
| WELTKEGFMTSFALF | 101 | Q9BUV8 | |
| AAFWQMDGPLLKEFI | 506 | Q8NDN9 | |
| FPTFKFQPRHDSMDW | 21 | Q8IYY4 | |
| STSTIPKMLGIFWFN | 76 | Q8NGH9 | |
| MFPREKTWNISFAGC | 1 | Q96AD5 | |
| ETVWQLPMFSKFISF | 66 | P01906 | |
| DPVSFMFWKDEAFAL | 576 | P42898 | |
| AAAFFSTFMPERWFP | 251 | Q86WK9 | |
| FVKATTVGQMGWFFL | 291 | Q96A54 | |
| SWDPMFTFLLTKEGA | 346 | P59901 | |
| NLEFSSFMFWRNPLP | 151 | Q9ULX3 | |
| SDGRVIFFLPWQKMT | 336 | P43304 | |
| SFKMDPLISWQSGFV | 151 | Q9HCP6 | |
| IRKFMFGFPENWKEH | 456 | Q6P0N0 | |
| IWDSQLPGFIFNDMF | 1061 | Q2M2H8 | |
| SGLPAAFSTFEWMKV | 196 | Q9GZZ0 | |
| RVFKMSFVPVGFWQR | 1016 | Q38SD2 | |
| MYPAFAESFWSKLEV | 696 | Q9H252 | |
| LFWGSFFGSIFMLSP | 51 | Q6UWP7 | |
| STATIPKMLGIFWFN | 76 | Q96RD3 | |
| MSATGFLWSLQQFPK | 3221 | Q96JB1 | |
| CFARVWFSEKMFEPS | 4131 | Q96JB1 | |
| PKWNTKRMGSISFDF | 461 | Q9Y4C0 | |
| DSGSFWLKMTPFGFR | 1716 | P09848 | |
| GFEVAMKFLNWATPN | 286 | O43772 | |
| SFRKLWAFTGPGFLM | 66 | P49281 | |
| FVMEGFLNLKWSRFA | 396 | P49281 | |
| KWSRMFFPITFSLFN | 451 | P18505 | |
| QFSMFLGKFSWFAGE | 141 | P21266 | |
| WQMESFFAKYPQAGA | 906 | Q07075 | |
| NPATVFFSVFMALWA | 406 | Q5XXA6 | |
| WPGFTDTFNMDTRKP | 16 | Q9UKX5 | |
| SNDLFPEHGFWISMK | 171 | Q6ZWI9 | |
| AFMLPWQFAQFILFT | 336 | Q6NUT2 | |
| NMSDDTWSAKVFFPL | 171 | Q9Y2T6 | |
| LLMPFRAFGDVKFKW | 346 | Q9P0J1 | |
| GKLFPEDMILNWFTQ | 96 | P51956 | |
| ALDLGAMTPFFWLFE | 191 | O75306 | |
| FQIFSQGISFPSWMK | 146 | Q9NUU6 | |
| GFMLAFGDMAWVPFT | 256 | O76062 | |
| GWAVNYLPFFLMEKT | 646 | Q9Y6A1 | |
| MTPSFFEENILGKKW | 3671 | Q9C0G6 | |
| PGESFCDKVMRWFQA | 146 | P24001 | |
| SPGMFNFDTFWKNFK | 351 | Q6E0U4 | |
| NSNMVGKIWIPDTFF | 136 | Q8N1C3 | |
| FRAQWMFELAPGVSS | 46 | Q9UK97 | |
| MVGKIWIPDTFFRNS | 141 | P18507 | |
| LSHWPFFEAFRKFLM | 316 | Q5VZ89 | |
| FGKMCSEFWLPDTFG | 361 | Q9NTJ4 | |
| ADLVFPWFVFIMGSS | 306 | Q68CP4 | |
| GFVEFKISGPLQYMW | 371 | Q8WWI5 | |
| YFKTLTPWGVFLENM | 826 | Q9UHC6 | |
| ESVNLFEWMAPLFEK | 281 | A6NKP2 | |
| FEWMAPLFEKLGYSQ | 286 | A6NKP2 | |
| GDFTMPSTVWLTGFF | 4336 | Q9NYC9 | |
| VINWFMSFGPEIKLN | 91 | Q5XKR9 | |
| FSFLDPFSPAVWLFM | 536 | Q16478 | |
| FWNFMLFLQKSQRPG | 71 | A0A1B0GVD1 | |
| MLWTFDNRFLKNFVP | 506 | Q9BRP7 | |
| MLSFHFWKSRGQPTD | 1 | D6RIA3 | |
| WFSFFPLLGRLMEFV | 221 | Q8N4W6 | |
| EDYLPSFCKWAGDFM | 211 | P51530 | |
| KLTPAQWFLREGSMF | 111 | P21453 | |
| SLDWKGNSFKPETMF | 2226 | Q9NZJ4 | |
| SFPNWEFARMIKEFR | 226 | Q99661 | |
| FMDVFTWSLPFVGEK | 346 | Q08209 | |
| DGFIWSRNMCSFPKT | 281 | Q56UN5 | |
| AFMLPWQFAQFILFT | 146 | Q6ZN68 | |
| TFAKVWFSENMFGPD | 4266 | Q8TE73 | |
| TSDFMPWNVFDGKLF | 796 | Q96EK7 | |
| MFPANWTSVKVFFFL | 1 | Q8NGS4 | |
| STATIPKMLGIFWFN | 76 | Q8NH55 | |
| MKSFVLGWPTVNFVA | 151 | Q9P2F6 | |
| FLRKFMWGTFPGCLA | 91 | Q96EL2 | |
| FFGLAPGWVVNMADK | 266 | Q9P015 | |
| WHISKPGQFETFDLM | 761 | Q07890 | |
| PNEWAMAKSGFAFSS | 831 | Q8WUY3 | |
| PQFRFDWFIKSRTAM | 996 | P28370 | |
| TAFGNMDKFPFNWKL | 106 | Q14DG7 | |
| FIMMPFASEFFPRTW | 91 | P0DP42 | |
| MTIFGVLFKFWPQFC | 1121 | Q8NE09 | |
| MFMQFSDLPFFWRTS | 451 | P58743 | |
| GKMKRIAFQFTPYSW | 286 | Q9BVG9 | |
| VLGSFWNKDPFLDMI | 21 | Q8NEX5 | |
| MSDDFLWFEGIAFPT | 1 | Q06520 | |
| REFKEWFSNPLTGMI | 801 | Q6ZRS2 | |
| NNFPFSSWGEALFLM | 96 | O75352 | |
| TEDFRMFKNGSFWRP | 491 | O15042 | |
| PFSATMEVLGFWAFG | 151 | P25100 | |
| SSEQFEKWRFSMPFK | 421 | Q7LGC8 | |
| VEMQKFLGSFFIGWD | 361 | Q9Y2G3 | |
| RFLGFFMVPAQSSWN | 2266 | Q6P2Q9 | |
| FFFNPTMHLSVWEKP | 356 | Q5VWI1 | |
| NFMDVFTWSLPFVGE | 341 | P48454 | |
| VPHNMTEKEFWTRFF | 211 | P32780 | |
| MFFNREDVLWFKPVE | 716 | Q2NL82 | |
| KSWGPLSFMDVFVDF | 76 | Q14587 | |
| EWSRKAFGMQSIFGP | 601 | O14924 | |
| TLFRSQPKSGWSFML | 266 | Q9Y6Q2 | |
| FMFDEKLVTVWSAPN | 246 | O00743 | |
| PFRKSWMAPEALNFS | 196 | Q8NE28 | |
| KGIQFFDRIKLFWMP | 951 | Q6U841 | |
| FKGMFALLFPWACGT | 871 | Q6ZT07 | |
| HFWMFFILPGVTERK | 2271 | Q9H5I5 | |
| FDWSSFKPMGFEVSF | 2581 | O60281 | |
| MKLEDFWCAQFTAFP | 511 | Q8IZ13 | |
| FFWEERDIMAFANSP | 136 | O75116 | |
| SQYPMEWGKTFLAFL | 126 | Q86VZ5 | |
| MWFSRKFLDFPIGNT | 176 | Q9UBV4 | |
| NKLWGTTLFMAGFFT | 206 | Q9P1P5 | |
| KWQTAGMFRPFVEVT | 1451 | O14795 | |
| ISSMADFWDFAQGPL | 151 | Q9P0L9 | |
| MWLQDRIATFFFPKG | 1 | E9PQX1 | |
| FMGDDTWKDLFPGAF | 176 | Q8TEQ8 | |
| WAQKLMFNSPGFVEY | 426 | Q16401 | |
| HFPASPFWSVMFFLM | 451 | Q9H1V8 | |
| IWFFGRFLKNEPRME | 411 | Q9H0C3 | |
| FIWSVFSPKLLYEGM | 946 | Q5H8A4 | |
| WTLFVPTNDAFKGMT | 531 | Q15063 | |
| FGAHWMKAPISFSKV | 131 | O60806 | |
| FDLPRTNIGKFDMIW | 136 | P51580 | |
| VAAWLMSYKPALFGF | 16 | H3BTG2 | |
| LVFMLCSNFWFKFPG | 136 | Q8TDW0 | |
| FAPRLSFFWGIGMNF | 301 | P22033 | |
| PFMVNVTWDGKDLSF | 336 | Q12879 |